Send to

Choose Destination
J Infect Dis. 2017 Mar 15;215(6):844-846. doi: 10.1093/infdis/jix006.

Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.

Author information

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.


genital herpes; herpes simplex; vaccine; prophylaxis

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center